Listen: The Zolgensma lottery, billionaire philanthropy, & life on the buy side
What’s the right way to give drugs away? Is $3 billion even a lot of money? And when is biotech hype justified? We discuss all...
Tag : Listen
A podcast you may want to listen to
9th February 2020 The good thing about having different ideas about diet, obesity, diabetes and heart disease and suchlike, is that you get to meet...
Listen: Fake outbreak news, treating coronavirus, and biotech’s Mount Rushmore
Is peer review underrated? Can biotech stop an outbreak? And would you mind giving us a call? We discuss all that and more on the...
Listen: A chemist breaks bad, the latest on the coronavirus, and pharma’s slow Bern
Is it wise to lie to the feds? Is pharma taking Sen. Bernie Sanders seriously? And what constitutes a “public health emergency of international concern?”...
Listen: The latest on the China virus, Sarepta’s ongoing FDA saga, and biotech at Davos
Are we dealing with a SARS redux? Has the FDA lost its teeth? And what do billionaires talk to each other about? We discuss all...
Listen: A J.P. Morgan recap, a plan to bust pharma monopolies, and a website for cancer patients
Why weren’t there any big deals announced this week? What does the word “equivalar” mean? And why is information about prognosis so hard to find?...
Activating Audiences: How spatial music can help us to listen
Matthews, E-K; (2019) Activating Audiences: How spatial music can help us to listen. Organised Sound , 24 (3) pp. 297-306. 10.1017/s1355771819000360 . Green open access...
Researchers listen to rural Kentuckians—then score a win for heart health
Researchers who went into one of the nation’s poorest regions to educate people about their health ended up getting a few lessons themselves—and together, they...
Listen: Biohacker Josiah Zayner on getting canceled, good news in cancer, and a long road in Ebola
Does pharma deserve more credit? Will history forgive He Jiankui? And how does a laboratory eureka become a lifesaving vaccine? We discuss all that and...
Listen: The decade in breakthrough drugs, the year in bad CEOing, and the viruses that cure disease
Which drug defined the decade? Who’s the worst CEO in biopharma? And how does gene therapy actually work? We discuss all that and more on...
Listen: The future of CAR-T, an alarming cancer trend, and Sarepta’s FDA legacy
Has CAR-T lost its luster? Why is colorectal cancer on the rise? And did the FDA forever change in 2016? We discuss all that and...
Listen: Biogen’s big reveal, hot takes on Alzheimer’s, & the science of one-eyed sheep
How do you know if a “positive” study is positive? And what if clinical trial participants unionized? We discuss all that and more on the...
Listen: Warren’s awkward home front, the ethics of treating dwarfism, and the sound of STAT Summit
Can Sen. Elizabeth Warren ever go home again? Is it ethical to make little people taller? And when will AI come up with a new...
Listen: Google’s data grab, problematic genetic testing, & the perils of biotech Twitter
Do you trust Google with your health data? Is “Gattaca” an outdated reference? And what’s it like to get dunked on? We discuss all that...
Unlocking The Science Behind Hit Songs
What’s the science behind “hit songs?” What makes them so pleasurable? Source link...
Listen: An uncertain Alzheimer’s idea, blockbuster fish oil, & a little self-indulgence
Is the latest Alzheimer’s drug for real? Is three a crowd in CAR-T? And what’s a Bionomy? We discuss all that and more on the...
Listen: Drugs that don’t work, wearables in the desert, & excess ‘innovation’
When should a drug be pulled from shelves? How do you pronounce “HLTH?” And how does Ann Coulter decide what to tweet? We discuss all...
Listen: Every angle on Biogen’s shocking Alzheimer’s news
What exactly is Biogen doing? When is a press release worth $12 billion? And what should patients make of whiplashing news? We discuss all that...